Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-04-19 @ 10:18 AM
Study NCT ID:
NCT01624220
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2012-06-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Spinal Tumor | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Spinal tumor | View |
| None | Tumor of the mid or lower spine | View |
| None | Non-small cell lung cancer | View |
| None | Breast cancer | View |
| None | Prostate cancer | View |
| None | Renal cell cancer | View |
| None | Melanoma | View |
| None | Gastrointestinal cancer | View |
| None | Sarcoma | View |
| None | Thyroid cancer | View |
| None | Head and neck primary cancer | View |
| None | Carcinoma of unknown primary | View |
| None | Fiducial markers | View |
| None | Gold seed markers | View |
| None | Spinal stereotactic body radiation therapy | View |
| None | Spinal SBRT | View |
| None | Stereotactic Radiotherapy | View |